Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01763047 · ClinicalTrials.gov registry record · NA

Evaluation of the Performance of Investigational Contact Lenses in a Presbyopic Population

A NA study, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
298
Enrollment target

NCT01763047 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 298 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01763047, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
298 participants
Enrollment target

Study Summary

The objective of this study is to evaluate the performance of a novel multifocal lens system.

Interventions

  • DEVICE lotrafilcon B
  • DEVICE etafilcon A

Trial Details

FieldValue
Enrollment Target 298 participants
Start Date 2012-11
Est. Completion 2013-02
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT01763047

The ClinicalTrials.gov registry entry for NCT01763047 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 298 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which lotrafilcon B is the first listed.

NCT01763047 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01763047 about?

NCT01763047 is a clinical study titled "Evaluation of the Performance of Investigational Contact Lenses in a Presbyopic Population". The objective of this study is to evaluate the performance of a novel multifocal lens system.

What is the current status of trial NCT01763047?

This trial is currently completed. It is a NA study. The enrollment target is 298 participants. The study started on 2012-11. Estimated completion is 2013-02.

What interventions are being tested in trial NCT01763047?

The interventions under investigation include: lotrafilcon B (DEVICE), etafilcon A (DEVICE).

Who is sponsoring clinical trial NCT01763047?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.